EU health regulator aims for approval of antiviral drug as COVID-19 treatment


The European health regulator said on Monday it would look to fast-track the approval of Gilead Sciences’s antiviral remdesivir as a potential COVID-19 treatment in Europe after the U.S. drugmaker submitted its marketing application. Remdesivir, the first drug to show improvement in COVID-19 patients in formal trials, has been cleared for emergency use in severely-ill patients in the United States, India and South Korea.